[go: up one dir, main page]

CN102895706B - Biomedical anti-corrosion porous compound material and preparation method thereof - Google Patents

Biomedical anti-corrosion porous compound material and preparation method thereof Download PDF

Info

Publication number
CN102895706B
CN102895706B CN201210449859.1A CN201210449859A CN102895706B CN 102895706 B CN102895706 B CN 102895706B CN 201210449859 A CN201210449859 A CN 201210449859A CN 102895706 B CN102895706 B CN 102895706B
Authority
CN
China
Prior art keywords
magnesium
alloy
porous
magnesium alloy
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210449859.1A
Other languages
Chinese (zh)
Other versions
CN102895706A (en
Inventor
黄美娜
潘复生
汤爱涛
彭建
潘虎成
王丹丹
姚丹丹
韩梦娇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing University
Original Assignee
Chongqing University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing University filed Critical Chongqing University
Priority to CN201210449859.1A priority Critical patent/CN102895706B/en
Publication of CN102895706A publication Critical patent/CN102895706A/en
Application granted granted Critical
Publication of CN102895706B publication Critical patent/CN102895706B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

本发明涉及一种生物医用耐蚀多孔复合材料及其制备方法,该多孔复合材料由多孔镁合金基体、预处理层和聚合物涂层组成;多孔镁合金基体为镁含量>90%的镁锌合金、镁钙合金、镁锂合金、镁锶合金或由上述体系合金成分组成的三元系合金;多孔镁合金基材的孔径为100~1200μm,闭孔的孔深度为100~500μm,孔隙率为30~70%;预处理层为氧化/磷化层,厚度为1~10μm;聚合物涂层为可降解、脂肪族高分子材料层,厚度为5~30μm。制备方法包括制备多孔镁合金基材、在多孔镁合金基材表面及孔内获得氧化膜作为后续聚合物涂层的中间层和涂覆高分子聚合物层。本发明降低了多孔镁合金基体的腐蚀速度,并提高了其强韧性。The invention relates to a biomedical corrosion-resistant porous composite material and a preparation method thereof. The porous composite material is composed of a porous magnesium alloy substrate, a pretreatment layer and a polymer coating; the porous magnesium alloy substrate is magnesium zinc with a magnesium content > 90%. alloy, magnesium-calcium alloy, magnesium-lithium alloy, magnesium-strontium alloy, or ternary alloys composed of the alloy components of the above systems; the pore diameter of the porous magnesium alloy substrate is 100-1200 μm, the pore depth of the closed cells is 100-500 μm, and the porosity The pretreatment layer is an oxidation/phosphating layer with a thickness of 1-10 μm; the polymer coating is a degradable and aliphatic polymer material layer with a thickness of 5-30 μm. The preparation method includes preparing a porous magnesium alloy base material, obtaining an oxide film on the surface of the porous magnesium alloy base material and in the pores as an intermediate layer of a subsequent polymer coating, and coating a high molecular polymer layer. The invention reduces the corrosion rate of the porous magnesium alloy substrate and improves its strength and toughness.

Description

一种生物医用耐蚀多孔复合材料及其制备方法A biomedical corrosion-resistant porous composite material and preparation method thereof

技术领域 technical field

本发明涉及医疗器械中骨科内固定材料,属于生物医疗器械领域,具体涉及一种可用作骨修复的生物医用耐蚀多孔复合材料及其制备方法。 The invention relates to orthopedic internal fixation materials in medical devices, belonging to the field of biomedical devices, in particular to a biomedical corrosion-resistant porous composite material that can be used for bone repair and a preparation method thereof.

背景技术 Background technique

骨组织损伤修复一直是临床医学致力解决的重大问题。源于自然灾害、交通事故、工伤、运动创伤、骨肿瘤切除、以及代谢性骨质疏松(OP)、先天性骨疾病等骨损伤成为威胁人们健康的重大疾病之一。目前,金属材料在骨修复方面仍具有重要作用,与陶瓷材料、高分子聚合材料相比金属具有高机械强度及断裂韧性,适合用于负重区域。应用的金属生物材料包括不锈钢、钴基合金以及钛及钛合金、Ni-Ti合金和镁合金材料,其中镁合金材料的应用更广泛。现用金属材料的一个缺陷是通过腐蚀或摩擦有可能释放毒素或者颗粒,因此导致炎症,从而降低生物相容性及导致组织磨损。更为重要的是这类金属材料的弹性模量与天然骨不匹配,容易产生应力遮挡作用。采用镁合金作为骨修复材料,具有很多的优点:1)力学匹配性:弹性模量约为41~45GPa、其密度为1.7~1.9g/cm3与天然骨相当;2)生物学特性:镁具有良好的生物相容性,其还是众多酶的共同因子,又是能量转运、存储和利用的关键元素,能调节、稳定RNA和DNA的结构,对调节细胞的生长和维持细胞膜结构具有重要作用;3)安全性,镁对人体无害,具有良好的生物相容性,过量的镁可以通过尿液排出体外;4)生物可降解性、可吸收性;5)局部碱性环境促进骨诱导作用,促进新骨生成。 The repair of bone tissue injury has always been a major problem in clinical medicine. Bone injuries caused by natural disasters, traffic accidents, industrial injuries, sports trauma, bone tumor resection, metabolic osteoporosis (OP), and congenital bone diseases have become one of the major diseases that threaten people's health. At present, metal materials still play an important role in bone repair. Compared with ceramic materials and polymer materials, metals have high mechanical strength and fracture toughness, and are suitable for use in load-bearing areas. Applied metal biomaterials include stainless steel, cobalt-based alloys, titanium and titanium alloys, Ni-Ti alloys, and magnesium alloys, among which magnesium alloys are more widely used. A drawback of currently used metallic materials is the potential release of toxins or particles through corrosion or friction, thus causing inflammation, thereby reducing biocompatibility and causing tissue wear. More importantly, the elastic modulus of such metal materials does not match that of natural bone, which is prone to stress shielding. The use of magnesium alloy as a bone repair material has many advantages: 1) Mechanical compatibility: the elastic modulus is about 41-45GPa, and its density is 1.7-1.9g/ cm3 , which is equivalent to natural bone; 2) Biological characteristics: Magnesium It has good biocompatibility, it is also a common factor of many enzymes, it is also a key element of energy transport, storage and utilization, it can regulate and stabilize the structure of RNA and DNA, and it plays an important role in regulating cell growth and maintaining cell membrane structure ;3) Safety, magnesium is harmless to the human body, has good biocompatibility, excess magnesium can be excreted through urine; 4) biodegradability, absorbability; 5) local alkaline environment promotes osteoinduction function to promote new bone formation.

但是镁合金作为骨修复材料仍然存在着诸多方面的不足: However, magnesium alloys still have many deficiencies as bone repair materials:

(1)镁合金耐腐蚀性差,性能活泼,易腐蚀生成氧化膜:南京医科大学的研究表明,由于镁合金的该性质,作为牙科骨修复材料植入后产生了疏松多孔,不能对其实验中的牙龈基底产生保护作用。该实验室为了解决镁合金在人体中的耐腐性差的关键问题,采用了微弧氧化法对镁合金进行表面处理取得了比较理想的效果。 (1) Magnesium alloy has poor corrosion resistance, lively performance, and is easy to corrode to form oxide film: the research of Nanjing Medical University shows that due to the nature of magnesium alloy, it is loose and porous after being implanted as a dental bone repair material, which cannot be used in the experiment. Protects the gingival base. In order to solve the key problem of poor corrosion resistance of magnesium alloys in the human body, the laboratory adopted the micro-arc oxidation method to treat the surface of magnesium alloys and achieved relatively ideal results.

(2)镁合金降解速度快,镁合金在人体内生物降解速度过快,往往在骨折固定愈合尚未完全稳定之前就腐蚀严重,而且过快的腐蚀降解速度会造成力学强度大幅度降低,降低骨折固定的能力,同时过量释放的镁离子及过高的pH值引发BMP-2的过量分泌,从而激活破骨细胞,导致溶骨现象的产生。 (2) The degradation speed of magnesium alloy is fast. The biodegradation speed of magnesium alloy in the human body is too fast, and it often corrodes seriously before the fracture fixation and healing are not completely stable, and the excessive corrosion degradation speed will cause a significant decrease in mechanical strength and reduce the risk of fracture. At the same time, the excessive release of magnesium ions and the high pH value trigger the excessive secretion of BMP-2, thereby activating osteoclasts and resulting in osteolysis.

(3)镁离子的吸收与VD,钙、磷的吸收具有重要的相互作用关系:镁离子过量,产生镁代谢紊乱时,会抑制钙磷的沉降及吸收,导致钙吸收失衡,新骨生成延缓。 (3) The absorption of magnesium ions has an important interaction with the absorption of VD, calcium and phosphorus: excessive magnesium ions will inhibit the precipitation and absorption of calcium and phosphorus when magnesium metabolism is disordered, resulting in imbalance of calcium absorption and delay of new bone formation .

镁合金上述诸多方面的不足限制了其的应用,为了提高镁合金的应用价值,降低其使用过程中所带来的副作用,通过各种改性方法对镁合金进行腐蚀保护是一个重要的过程。 The deficiencies in the above aspects of magnesium alloy limit its application. In order to improve the application value of magnesium alloy and reduce the side effects caused by its use, it is an important process to protect magnesium alloy from corrosion through various modification methods.

为了解决上述存在的问题,现有技术开始使用多孔镁及其合金来作为骨修复材料,这主要是基于多孔镁及其合金其质轻和优良力学性能,将多孔镁及其合金用于骨修复中可以如聚合物多孔支架、陶瓷多孔支架一样为细胞提供三维生长空间,有利于养料及代谢物得交换运输,其本身诱导的生物活性可诱导细胞分化生长和血管长入。 In order to solve the above-mentioned problems, the prior art begins to use porous magnesium and its alloys as bone repair materials, which is mainly based on the light weight and excellent mechanical properties of porous magnesium and its alloys, and the use of porous magnesium and its alloys for bone repair Like polymer porous scaffolds and ceramic porous scaffolds, it can provide three-dimensional growth space for cells, which is conducive to the exchange and transportation of nutrients and metabolites. The biological activity induced by itself can induce cell differentiation and growth and blood vessel growth.

目前关于多孔镁合金在骨修复方面前景的探索逐渐增多,当前主要集中在:探索孔隙率、孔径大小与力学性能、降解性能的关系上多孔镁/镁合金与磷酸钙的复合多孔材料的降解性能研究、生物相容性研究。本发明以多孔镁合金为基底制备复合骨修复材料,采用的复合材料为可用于骨修复的聚合物,该复合骨修复材料兼具了镁合金、多孔结构和高分子材料的优点,但同时又能克服各自的缺点,在骨修复方面具有非常的应用前景,但迄今国内外鲜见研究报道。 At present, there are more and more explorations on the prospect of porous magnesium alloys in bone repair. At present, they mainly focus on: exploring the relationship between porosity, pore size and mechanical properties, and degradation properties. The degradation properties of porous magnesium/magnesium alloys and calcium phosphate composite porous materials research, biocompatibility studies. The invention uses porous magnesium alloy as the base to prepare composite bone repair material, and the composite material used is a polymer that can be used for bone repair. The composite bone repair material has the advantages of magnesium alloy, porous structure and polymer material, but at the same time They can overcome their respective shortcomings and have great application prospects in bone repair, but so far there are few research reports at home and abroad.

发明内容 Contents of the invention

针对现有技术存在的上述不足,本发明解决多孔镁合金在体内的腐蚀问题和力学性问题,提供一种多孔镁合金医用复合材料,以提高复合材料的抗腐蚀性能和强韧性,并且避免镁合金植入体内后产生过多的氢气及镁离子。 Aiming at the above deficiencies in the prior art, the present invention solves the corrosion and mechanical problems of porous magnesium alloys in the body, and provides a porous magnesium alloy medical composite material to improve the corrosion resistance and toughness of the composite material, and avoid magnesium After the alloy is implanted in the body, excessive hydrogen and magnesium ions are generated.

本发明还提供具有操作简便、实用性强的所述生物医用耐蚀多孔复合材料的制备方法。 The invention also provides a preparation method of the biomedical corrosion-resistant porous composite material with simple operation and strong practicability.

为解决上述技术问题,本发明采用如下技术方案,一种生物医用耐蚀多孔复合材料,其特征在于,由多孔镁合金基材、预处理层和聚合物涂层组成; In order to solve the above technical problems, the present invention adopts the following technical solution, a biomedical corrosion-resistant porous composite material, characterized in that it consists of a porous magnesium alloy substrate, a pretreatment layer and a polymer coating;

其中,多孔镁合金基材为镁含量大于90%的镁锌合金、镁钙合金、镁锂合金、镁锶合金或者由上述体系的合金成分组成的三元系合金;多孔镁合金基材的孔径为100~1200μm,闭孔的孔深度为100~500μm,孔隙率为30%~70%; Among them, the porous magnesium alloy substrate is a magnesium-zinc alloy, magnesium-calcium alloy, magnesium-lithium alloy, magnesium-strontium alloy or a ternary alloy composed of the above-mentioned alloy components with a magnesium content greater than 90%; the pore diameter of the porous magnesium alloy substrate 100-1200μm, the pore depth of closed cells is 100-500μm, and the porosity is 30%-70%;

预处理层为氧化/磷化层,厚度为1~10μm; The pretreatment layer is an oxidation/phosphating layer with a thickness of 1-10 μm;

聚合物涂层为可降解、脂肪族高分子材料层,厚度为5~30μm。 The polymer coating is a degradable, aliphatic polymer material layer with a thickness of 5-30 μm.

进一步,所述多孔镁合金基材为AZ31或Mg-Ca系列镁合金。所述的可降解、脂肪族高分子材料为聚乳酸、聚左旋聚乳酸、聚己内酯、聚酰胺或聚氨酯。 Further, the porous magnesium alloy substrate is AZ31 or Mg-Ca series magnesium alloy. The degradable and aliphatic polymer material is polylactic acid, poly-L-lactic acid, polycaprolactone, polyamide or polyurethane.

本发明还提供一种生物医用耐蚀多孔复合材料的制备方法,包括如下顺序步骤: The present invention also provides a method for preparing a biomedical corrosion-resistant porous composite material, comprising the following sequential steps:

1)多孔镁合金基材的制备: 1) Preparation of porous magnesium alloy substrate:

a、制备铸态镁钙、镁锂、镁锌和镁锶任意二种合金或所述元素组成的三元合金,该合金中除镁元素外,其他元素的重量占三元镁合金总重量百分比为<10%; a. Prepare any two alloys of as-cast magnesium-calcium, magnesium-lithium, magnesium-zinc and magnesium-strontium or a ternary alloy composed of said elements. In the alloy, except magnesium, the weight of other elements accounts for the total weight percentage of the ternary magnesium alloy <10%;

b、对所述多孔镁合金基材进行打孔处理; b. punching the porous magnesium alloy substrate;

2)多孔镁合金的预处理,在多孔镁合金基材表面及孔内采用氧化法获得分布均匀的氧化膜作为后续聚合物涂层的中间层,或采用磷化法获得分布均匀的磷化层作为后续聚合物涂层的中间层,所述氧化法为微弧氧化法、双氧水氧化法或碱化氧化法,氧化剂为H2O2或HF; 2) For the pretreatment of porous magnesium alloys, the oxidation method is used to obtain a uniformly distributed oxide film on the surface and inside the pores of the porous magnesium alloy substrate as the intermediate layer of the subsequent polymer coating, or the phosphating method is used to obtain a uniformly distributed phosphating layer As the intermediate layer of the subsequent polymer coating, the oxidation method is micro - arc oxidation method, hydrogen peroxide oxidation method or alkalization oxidation method, and the oxidizing agent is H2O2 or HF;

3)最后,将聚合物涂覆在多孔镁合金基材表面,通过改变聚合物的分子量、聚合物溶液的浓度、聚合物涂层的厚度,控制多孔镁合金基材与聚合物涂层的结合。 3) Finally, the polymer is coated on the surface of the porous magnesium alloy substrate, and the combination of the porous magnesium alloy substrate and the polymer coating is controlled by changing the molecular weight of the polymer, the concentration of the polymer solution, and the thickness of the polymer coating .

进一步,所述步骤1)中打孔采用激光打孔或熔体发泡法调节多孔镁合金的孔径及孔隙率;熔体发泡法对镁锭、中间合金锭熔融,添加增稠剂、发泡剂进行熔融发泡,并调节发泡剂的含量及尺寸调节多孔镁合金的孔径及孔隙率;所述增稠剂为SiC或Ca;发泡剂为MgCO3、TiH2或ZrH2Further, in the step 1), laser drilling or melt foaming method is used to adjust the pore size and porosity of the porous magnesium alloy; the melt foaming method melts the magnesium ingot and the intermediate alloy ingot, and adds thickener, The foaming agent is melted and foamed, and the content and size of the foaming agent are adjusted to adjust the pore diameter and porosity of the porous magnesium alloy; the thickener is SiC or Ca; the foaming agent is MgCO 3 , TiH 2 or ZrH 2 .

所述步骤2)多孔镁合金预处理为碱洗/酸性,以及氧化/磷化法处理;所对应的试剂分别为:NaOH、H3PO4:HNO3、H2O2/HF、H3PO4/ZnO/NaF/NaNO3/NaNO2/Citric acid/MEA和SDS。 The step 2) the pretreatment of the porous magnesium alloy is alkali washing/acid, and oxidation/phosphating treatment; the corresponding reagents are: NaOH, H 3 PO 4 :HNO 3 , H 2 O 2 /HF, H 3 PO4 /ZnO/ NaF /NaNO3/NaNO2/Citric acid /MEA and SDS.

所述步骤3),采用浸润法或者滴液法将聚合物涂覆在多孔镁合金基材表面,或者真空渗流法进行高分子处理层的处理。 In the step 3), the polymer is coated on the surface of the porous magnesium alloy substrate by the soaking method or the dripping method, or the polymer treatment layer is treated by the vacuum infiltration method.

所述步骤2)进行磷化的过程如下: The process of performing phosphating in step 2) is as follows:

a)多孔镁合金基材清洗:酒精或丙酮清洗; a) Porous magnesium alloy substrate cleaning: alcohol or acetone cleaning;

b)碱洗脱脂:50℃的5%氢氧化钠溶液浸泡15min,水洗,待用; b) Alkaline washing and degreasing: soak in 5% sodium hydroxide solution at 50°C for 15 minutes, wash with water, and set aside;

c)磷化处理:在室温下,磷化液中浸泡处理15min;磷化液的配方如下:磷酸:25~35mL/L,氧化锌:1~2g/L,氟化钠:1~3g/L,亚硝酸钠:1~2g/L,硝酸钠:2~4g/L,焦磷酸钠:2~4g/L,乙醇胺:0.1~2g/L。 c) Phosphating treatment: Soak in phosphating solution for 15 minutes at room temperature; formula of phosphating solution is as follows: phosphoric acid: 25-35mL/L, zinc oxide: 1-2g/L, sodium fluoride: 1-3g/L L, sodium nitrite: 1~2g/L, sodium nitrate: 2~4g/L, sodium pyrophosphate: 2~4g/L, ethanolamine: 0.1~2g/L.

更进一步地,一种生物医用耐蚀多孔复合材料的制备方法,具体包括如下步骤: Furthermore, a method for preparing a biomedical corrosion-resistant porous composite material specifically includes the following steps:

1)多孔镁合金基材的准备; 1) Preparation of porous magnesium alloy substrate;

a1:取镁钙合金、镁锂合金、镁锌合金和镁锶合金中的任意两种制备铸态三元镁合金,该铸态三元镁合金中除镁元素外,其他元素的重量占三元镁合金总重量百分比为<10%;在300~350℃的条件下制成挤压态的三元镁合金; a1: Take any two of magnesium-calcium alloy, magnesium-lithium alloy, magnesium-zinc alloy and magnesium-strontium alloy to prepare as-cast ternary magnesium alloy. In the as-cast ternary magnesium alloy, except for magnesium, the weight of other elements accounts for three The total weight percentage of elemental magnesium alloy is <10%; it is made into extruded ternary magnesium alloy under the condition of 300-350°C;

a2:采用激光打孔机对上述挤压态的三元镁合金打孔,孔径为100~1200μm,闭孔的孔深度为100~500μm,孔隙率为30~70%; a2: Use a laser drilling machine to drill holes in the extruded ternary magnesium alloy, with a pore diameter of 100-1200 μm, a closed hole depth of 100-500 μm, and a porosity of 30-70%;

2)制备预处理层为氧化层或磷化层; 2) Prepare the pretreatment layer as an oxide layer or a phosphating layer;

b1:氧化层的制备: b1: Preparation of oxide layer:

采用纯酒精或纯丙酮对步骤1)准备的多孔镁合金基材进行清洗,清洗至无杂质; Clean the porous magnesium alloy substrate prepared in step 1) with pure alcohol or pure acetone until there are no impurities;

配制浓度为10%~30%的H2O2氧化液或浓度为10%~30%的HF氧化液,将经清洗后的多孔镁合金基材浸泡于该氧化液中进行氧化处理,该氧化处理在室温下进行,处理时间为60s-600s; Prepare H 2 O 2 oxidation solution with a concentration of 10% to 30% or HF oxidation solution with a concentration of 10% to 30%, soak the cleaned porous magnesium alloy substrate in the oxidation solution for oxidation treatment, the oxidation The treatment is carried out at room temperature, and the treatment time is 60s-600s;

b2:磷化层的制备: b2: Preparation of phosphating layer:

采用纯酒精或纯丙酮对步骤1)准备的多孔镁合金基材进行清洗,清洗至无杂质; Clean the porous magnesium alloy substrate prepared in step 1) with pure alcohol or pure acetone until there are no impurities;

将经过上述清洗的多孔镁合金基材在温度为50℃的条件下,浓度为5%氢氧化钠溶液中浸泡15min,然后水洗;再将该多孔镁合金基材浸泡于磷化液中进行磷化处理,该磷化处理在室温条件下进行,处理时间为15min;其中,磷化液的配方为,1升磷化液中分别含磷酸25~35mL,氧化锌1~2g,氟化钠1~3g,亚硝酸钠1~2g,硝酸钠2~4g,焦磷酸钠2~4g,乙醇胺0.1~2g; Soak the porous magnesium alloy base material cleaned above at a temperature of 50°C in a 5% sodium hydroxide solution for 15 minutes, and then wash it with water; then soak the porous magnesium alloy base material in a phosphating solution for phosphorus Phosphating treatment, the phosphating treatment is carried out at room temperature, and the treatment time is 15 minutes; wherein, the formula of the phosphating solution is that 1 liter of the phosphating solution contains 25-35 mL of phosphoric acid, 1-2 g of zinc oxide, and 1 g of sodium fluoride. ~3g, sodium nitrite 1~2g, sodium nitrate 2~4g, sodium pyrophosphate 2~4g, ethanolamine 0.1~2g;

3)可降解、脂肪族高分子材料层的制备: 3) Preparation of degradable and aliphatic polymer material layer:

c1、取平均分子量为5~30万的可降解、脂肪族高分子材料溶于易挥发的有机溶剂中,使可降解、脂肪族高分子材料的浓度为1%~10%;所述易挥发的有机溶剂为二氯甲烷、三氯甲烷、丙酮或四氢呋喃; c1. Take a degradable and aliphatic polymer material with an average molecular weight of 50,000 to 300,000 and dissolve it in a volatile organic solvent, so that the concentration of the degradable and aliphatic polymer material is 1% to 10%; the volatile The organic solvent is dichloromethane, chloroform, acetone or tetrahydrofuran;

将经过步骤2)处理的多孔镁合金基材浸泡于c1的溶液中,提出,然后在室温~60℃条件下将溶剂完全挥发; soaking the porous magnesium alloy substrate treated in step 2) in the solution of c1, extracting it, and then completely volatilizing the solvent at room temperature to 60°C;

或将步骤c1制备的溶液分次滴定于经过步骤2)处理的多孔镁合金基材各表面上,然后在室温~60℃条件下将溶剂完全挥发。该方案中所述步骤1)的多孔镁合金基材采用熔体发泡法调节多孔镁合金的孔径及孔隙率,将步骤1)的铸态三元镁合金熔融,向其中添加增粘剂、发泡剂进行熔融发泡,通过调节发泡剂的含量及尺寸使多孔镁合金的孔径、孔深度和孔隙率,制成多孔镁合金基材。 Or titrate the solution prepared in step c1 on each surface of the porous magnesium alloy substrate treated in step 2), and then completely volatilize the solvent at room temperature to 60°C. The porous magnesium alloy base material in step 1) described in the scheme uses a melt foaming method to adjust the pore diameter and porosity of the porous magnesium alloy, melts the cast ternary magnesium alloy in step 1), and adds a tackifier, The foaming agent is melted and foamed, and the pore diameter, pore depth and porosity of the porous magnesium alloy are adjusted by adjusting the content and size of the foaming agent to prepare a porous magnesium alloy substrate.

本发明中所用的增粘剂为SiC或Ca。SiC作为增粘剂可以与金属生成一种复合物,从而保持金属在较低的搅拌温度;Ca粒作为增粘剂的同时还具有阻止镁合金燃烧的作用,同时引入更少的杂质元素,降低镁合金基材的腐蚀点。所用的发泡剂为MgCO3、TiH2或ZrH2。其中MgCO3具有廉价、易得的特点;TiH2和ZrH2因释放发泡气体H2的最快温度是600℃与镁的熔点(640℃)较为接近,因此是众多氢化物中效果最佳的发泡剂。 The tackifier used in the present invention is SiC or Ca. As a tackifier, SiC can form a composite with the metal, thereby keeping the metal at a lower stirring temperature; as a tackifier, Ca particles can also prevent the combustion of magnesium alloys, and at the same time introduce less impurity elements, reducing Corrosion points of magnesium alloy substrates. The blowing agent used is MgCO 3 , TiH 2 or ZrH 2 . Among them, MgCO 3 is cheap and easy to obtain; TiH 2 and ZrH 2 have the best effect among many hydrides because the fastest temperature for releasing foaming gas H 2 is 600 ° C and the melting point of magnesium (640 ° C) is relatively close foaming agent.

所用的可降解、脂肪族高分子材料为聚乳酸、聚乳酸-羟基乙酸共聚物、聚己内酯、聚酰胺或聚氨酯,主要从高分子材料在生物医学方面的应用出发,其中聚乳酸获得了FDA的批准,制作聚乳酸骨钉、骨板和聚乳酸固定材料,甚至用作制备聚乳酸止血胶;聚酰胺与天然骨中的胶原具有类似的结构,因此经常与羟基磷灰石复合制备骨修复材料;另外,其它几种高分子材料也因其优良的力学性能、降解性能广泛用于骨修复中。 The degradable and aliphatic polymer materials used are polylactic acid, polylactic acid-glycolic acid copolymer, polycaprolactone, polyamide or polyurethane, mainly from the application of polymer materials in biomedicine, in which polylactic acid has obtained FDA approval, making polylactic acid bone nails, bone plates and polylactic acid fixation materials, even used to prepare polylactic acid hemostatic glue; polyamide has a similar structure to collagen in natural bone, so it is often combined with hydroxyapatite to prepare bone Repair materials; In addition, several other polymer materials are also widely used in bone repair because of their excellent mechanical properties and degradation properties.

本发明选择了四种易挥发的溶剂,主要从高分子材料层的效果及操作难易程度来考虑,易挥发的溶剂可以在较低的温度下缓慢挥发,制得表面光滑、无孔隙的高分子膜。其中,二氯甲烷和三氯甲烷溶剂25℃的条件下,24h可以基本挥发完毕;四氢呋喃、丙酮在37℃的条件下,24h可以基本挥发完毕,如果将温度提高可以进一步加速溶剂挥发,因此可以简单、快捷地制得高分子材料膜。 The present invention selects four kinds of volatile solvents, mainly considering the effect of the polymer material layer and the ease of operation. The volatile solvents can be slowly volatilized at a lower temperature to obtain a smooth surface and no pores. Molecular membrane. Among them, dichloromethane and trichloromethane solvents can be basically volatilized in 24 hours under the condition of 25°C; tetrahydrofuran and acetone can be basically volatilized in 24 hours under the condition of 37°C. If the temperature is increased, the solvent volatilization can be further accelerated, so it can be The polymer material film is prepared simply and quickly.

相比现有技术,本发明具有如下有益效果: Compared with the prior art, the present invention has the following beneficial effects:

1、本发明采用了多孔镁合金基材与可用于骨修复的聚合物复合,将镁合金的弹性模量、密度与天然骨的匹配性及与聚合物的韧性、耐腐蚀性结合起来,进一步降低了多孔镁合金基材在体内的腐蚀速度,同时还显著提高了复合材料的强韧性。 1. The present invention adopts the composite of porous magnesium alloy base material and the polymer that can be used for bone repair, and combines the elastic modulus and density of the magnesium alloy with the matching property of natural bone and the toughness and corrosion resistance of the polymer, further The corrosion rate of the porous magnesium alloy substrate in the body is reduced, and the strength and toughness of the composite material are also significantly improved.

2、本发明通过调节多孔镁合金基材与预处理层及高分子材料层的比例,可以方便控制材料的力学性能,使复合材料的力学性能与天然骨的力学性能更加匹配。 2. By adjusting the ratio of the porous magnesium alloy base material to the pretreatment layer and the polymer material layer, the present invention can conveniently control the mechanical properties of the material, so that the mechanical properties of the composite material can better match those of natural bone.

3、本发明通过调节预处理层的成分来控制高分子材料层与多孔镁合金基材的结合力,从而更加可控地调节复合材料的可降解性。实现复合材料在体内的降解吸收速度可控,解决镁合金在人体环境中腐蚀降解速度较快,而可降解、脂肪族高分子材料在体内降解速度相对较慢的矛盾,通过调节多孔镁合金基材与高分子材料的含量及高分子材料层的厚度,有效控制复合材料在体内的降解速度。 3. The present invention controls the bonding force between the polymer material layer and the porous magnesium alloy substrate by adjusting the composition of the pretreatment layer, thereby more controllably adjusting the degradability of the composite material. Realize the controllable degradation and absorption speed of composite materials in vivo, and solve the contradiction that the corrosion and degradation speed of magnesium alloy is relatively fast in the human environment, while the degradation speed of degradable and aliphatic polymer materials is relatively slow in vivo. By adjusting the porous magnesium alloy matrix The content of the polymer material and the polymer material and the thickness of the polymer material layer can effectively control the degradation rate of the composite material in the body.

4、本发明考虑了复合材料的各向力学性能、腐蚀降解性能、生物相容性,更考虑了多孔结构植入后,人体的血管和肌肉可以长入体内,便于人体组织运送血供和营养;通过调节多孔镁合金基材与预处理层及高分子材料层的比例,调节复合支架的大孔-微纳孔比例,从而调节了骨修复过程中的血供和肌肉生长速度。 4. The present invention considers the isotropic mechanical properties, corrosion degradation performance, and biocompatibility of composite materials, and also considers that after the porous structure is implanted, blood vessels and muscles of the human body can grow into the body, which is convenient for human tissues to transport blood supply and nutrition ; By adjusting the ratio of the porous magnesium alloy base material to the pretreatment layer and the polymer material layer, the macropore-micro-nanopore ratio of the composite scaffold is adjusted, thereby regulating the blood supply and muscle growth rate in the bone repair process.

5、本发明生物医用耐蚀多孔复合材料的制备方法,步骤简捷、容易控制,通过控制参数来控制其孔隙率、孔径和孔的连通性来控制多孔复合材料的降解性。 5. The preparation method of the biomedical corrosion-resistant porous composite material of the present invention has simple steps and is easy to control. The degradability of the porous composite material is controlled by controlling the parameters to control the porosity, pore diameter and pore connectivity.

附图说明 Description of drawings

图1为采用激光打孔法制备的多孔AZ31基材。 Figure 1 shows the porous AZ31 substrate prepared by laser drilling method.

图2为采用发泡法制备的孔径、孔深各不相同的多孔镁、钙、锌三元镁合金基材。图2a的平均孔径为3000μm、平均孔深为3000μm;图2b的平均孔径为2000μm、平均孔深为2000μm;图2c的平均孔径为1000μm、平均孔深为1000μm;图2d的平均孔径为500μm、平均孔深为500μm;其中,平均孔径和平均孔深是任意选取多孔镁、钙、锌三元镁合金基材上的15个孔所做的平均值。 Fig. 2 shows porous magnesium, calcium, zinc ternary magnesium alloy substrates with different pore diameters and pore depths prepared by foaming method. The average pore diameter of Figure 2a is 3000 μm, and the average pore depth is 3000 μm; the average pore diameter of Figure 2b is 2000 μm, and the average pore depth is 2000 μm; the average pore diameter of Figure 2c is 1000 μm, and the average pore depth is 1000 μm; The average pore depth is 500 μm; wherein, the average pore diameter and average pore depth are the average values of 15 pores randomly selected on the porous magnesium, calcium, zinc ternary magnesium alloy substrate.

图3 镁合金基材及预处理层、高分子层。图3a为AZ31基材;图3b为氧化预处理层;图3c为磷化预处理层;图3d为高分子涂层。 Figure 3 Magnesium alloy substrate, pretreatment layer, and polymer layer. Figure 3a is the AZ31 substrate; Figure 3b is the oxidation pretreatment layer; Figure 3c is the phosphating pretreatment layer; Figure 3d is the polymer coating.

图4多孔AZ31基材及多孔AZ31复合材料。图 4a 为多孔AZ31基材;图4b为多孔AZ31基材孔外(×50);图4c多孔AZ31基材孔内(×50);图 4d 为多孔AZ31复合材料;图4e为多孔AZ31复合材料孔外(×50);图4f多孔AZ31复合材料孔内(×50)。其中图4b,图4c,图4e,图4f中的(×50)表示放大倍数。 Figure 4 Porous AZ31 substrate and porous AZ31 composite. Figure 4a is porous AZ31 substrate; Figure 4b is outside the pores of porous AZ31 substrate (×50); Figure 4c is inside the pores of porous AZ31 substrate (×50); Figure 4d is porous AZ31 composite material; Figure 4e is porous AZ31 composite material Outside the pores (×50); Fig. 4f Inside the pores of the porous AZ31 composite (×50). Among them, (×50) in Figure 4b, Figure 4c, Figure 4e, and Figure 4f indicates the magnification.

图5 SBF浸泡三个月后AZ31材料腐蚀对照图。图5a为多孔AZ31材料腐蚀图;图5b 为无孔AZ31复合材料腐蚀图;图5c为闭孔AZ31复合材料腐蚀图;图5d为通孔AZ31复合材料腐蚀图。 Figure 5 Corrosion control diagram of AZ31 material after SBF immersion for three months. Figure 5a is the corrosion diagram of porous AZ31 material; Figure 5b is the corrosion diagram of non-porous AZ31 composite material; Figure 5c is the corrosion diagram of closed-pore AZ31 composite material; Figure 5d is the corrosion diagram of through-hole AZ31 composite material.

图 6 AZ31复合材料SEM及EDS 图。图6a为无孔AZ31复合材料SEM图;图6b为闭孔AZ31复合材料SEM图;图6c为通孔AZ31复合材料SEM图;图6d为通孔AZ31复合材料孔内SEM图;图6e为通孔AZ31复合材料孔外SEM图。其中,图6b和6c中的I和O分别表示多孔材料的孔内和孔外,图6a、6b和6c中的10、50和2000分别表示放大倍数。 Figure 6 SEM and EDS images of AZ31 composite material. Figure 6a is the SEM image of the non-porous AZ31 composite; Figure 6b is the SEM image of the closed-pore AZ31 composite; Figure 6c is the SEM image of the through-hole AZ31 composite; Figure 6d is the SEM image of the through-hole AZ31 composite; The SEM image of the hole outside the hole of the AZ31 composite material. Among them, I and O in Figures 6b and 6c represent the inside and outside of the pores of the porous material, respectively, and 10, 50 and 2000 in Figures 6a, 6b and 6c represent magnifications, respectively.

图7多孔AZ31基材、与实施例1-4多孔AZ31复合材料塔菲尔曲线对照图。 Fig. 7 is a comparison diagram of the porous AZ31 substrate and the Tafel curve of the porous AZ31 composite material in Examples 1-4.

图8多孔AZ31基材与实施例1-4多孔AZ31复合材料阻抗对照图。 Fig. 8 is a comparison diagram of the impedance of the porous AZ31 substrate and the porous AZ31 composite material of Examples 1-4.

图9多孔AZ31基材与实施例1-6多孔AZ31复合材料Mg2+释放图。 Fig. 9 Mg 2+ release diagram of the porous AZ31 substrate and the porous AZ31 composite material of Examples 1-6.

图10镁合金复合材料腐蚀示意图。 Fig. 10 Schematic diagram of corrosion of magnesium alloy composites.

具体实施方式 detailed description

以下结合附图和具体实施方式,对本发明作进一步详细说明。 The present invention will be described in further detail below in conjunction with the accompanying drawings and specific embodiments.

一种生物医用耐蚀多孔复合材料,由多孔镁合金基材、预处理层和聚合物涂层组成; A biomedical corrosion-resistant porous composite material is composed of a porous magnesium alloy substrate, a pretreatment layer and a polymer coating;

其中,多孔镁合金基材为镁含量大于90%的镁锌合金、镁钙合金、镁锂合金、镁锶合金或者由上述体系的合金成分组成的三元系合金(例如AZ31、Mg-Ca合金);多孔镁合金基材的孔径为100~1200μm,闭孔的孔深度为100~500μm,孔隙率为30%~70%;预处理层为氧化/磷化层,厚度为1~10μm;聚合物涂层为可降解、脂肪族高分子材料层,厚度为5~30μm。 Among them, the porous magnesium alloy substrate is a magnesium-zinc alloy, a magnesium-calcium alloy, a magnesium-lithium alloy, a magnesium-strontium alloy, or a ternary alloy composed of the above-mentioned alloy components (such as AZ31, Mg-Ca alloy, etc.) with a magnesium content greater than 90%. ); the pore diameter of the porous magnesium alloy substrate is 100-1200 μm, the pore depth of the closed cells is 100-500 μm, and the porosity is 30%-70%; the pretreatment layer is an oxidation/phosphating layer with a thickness of 1-10 μm; The material coating is a degradable, aliphatic polymer material layer with a thickness of 5-30 μm.

实施例1~6为生物医用耐蚀多孔复合材料,该复合材料的参数如表1(附后),选择生物医用的镁、钙、锂三元镁合金作为对比。采用电化学工作站测试材料的抗腐蚀性能;采用钨灯丝扫描电镜测试所有材料的表面形貌。 Examples 1-6 are corrosion-resistant porous composite materials for biomedical use. The parameters of the composite materials are shown in Table 1 (attached). A ternary magnesium alloy of magnesium, calcium and lithium for biomedical use was selected as a comparison. The corrosion resistance of the materials was tested by an electrochemical workstation; the surface morphology of all materials was tested by a tungsten filament scanning electron microscope.

实施例1:参见图4-5和图7-9,一种多孔镁合金医用复合材料的制备方法,包括如下步骤: Embodiment 1: Referring to Fig. 4-5 and Fig. 7-9, a method for preparing a porous magnesium alloy medical composite material comprises the following steps:

a、激光法制备多孔镁合金基材 a. Preparation of porous magnesium alloy substrate by laser method

基材为AZ31镁合金(购买的商品AZ31),将镁合金切割为Φ12×3的AZ31片材,然后采用激光打孔法制备多孔AZ31基材,该孔为闭孔,孔径为100μm,孔深为100μm,孔隙率为30%,最终制成多孔镁合金基材; The substrate is AZ31 magnesium alloy (purchased commodity AZ31), the magnesium alloy is cut into AZ31 sheets of Φ12×3, and then the porous AZ31 substrate is prepared by laser drilling method. The pores are closed pores with a diameter of 100 μm and a depth of 100μm, porosity 30%, finally made into porous magnesium alloy substrate;

b、多孔镁合金预处理层的方法: b, the method of porous magnesium alloy pretreatment layer:

制备多孔镁合金氧化层:配制浓度为15%的双氧水,常温下将多孔AZ31基材浸泡在双氧水中,持续2s,在多孔镁合金表面及孔内获得氧化层; Preparation of porous magnesium alloy oxide layer: prepare hydrogen peroxide with a concentration of 15%, soak the porous AZ31 substrate in hydrogen peroxide at room temperature for 2 seconds, and obtain an oxide layer on the surface and inside the pores of the porous magnesium alloy;

c、多孔AZ31高分子层的方法: c. The method of porous AZ31 polymer layer:

制备聚乳酸涂层,配制3wt.%聚乳酸的二氯甲烷溶液,将获得预处理层的多孔AZ31基材浸泡在聚乳酸的二氯甲烷溶液中,获得聚乳酸涂层,聚乳酸涂层的厚度为5μm。 Prepare the polylactic acid coating, prepare 3wt.% polylactic acid dichloromethane solution, soak the porous AZ31 substrate obtained with the pretreatment layer in the polylactic acid dichloromethane solution to obtain the polylactic acid coating, and the polylactic acid coating The thickness is 5 μm.

在进行多孔AZ31复合材料的耐蚀性能测试时选择了未处理的多孔AZ31,处理后的非多孔AZ31作为对照试验。 The untreated porous AZ31 was selected in the corrosion resistance test of the porous AZ31 composite, and the treated non-porous AZ31 was used as a control test.

图4多孔镁合金基材及多孔镁合金复合材料。图 4a 为多孔镁合金基材;图4b为多孔镁合金基材孔外(×50);图4c多孔镁合金基材孔内(×50);图 4a 为多孔镁合金复合材料;图4b为多孔镁合金复合材料孔外(×50);图4c多孔镁合金复合材料孔内(×50)。对照多孔AZ31复合材料和多孔AZ31基材可见,高分子层涂覆后多孔AZ31材料的孔外表面平滑、致密,但是闭孔内部较为粗糙,这主要是由于高分子材料涂覆时存在的界面效应,这一效应对高分子材料与基底的结合力存在着一定的影响,而且这种影响收到孔径和孔深的影响,孔径越小,界面效应越强,因此在实例1与后续实例对照抗腐蚀性能稍弱。 Fig. 4 Porous magnesium alloy substrate and porous magnesium alloy composite material. Figure 4a is the porous magnesium alloy substrate; Figure 4b is outside the pores of the porous magnesium alloy substrate (×50); Figure 4c is inside the pores of the porous magnesium alloy substrate (×50); Figure 4a is the porous magnesium alloy composite material; Figure 4b is Outside the pores of the porous magnesium alloy composite (×50); Figure 4c inside the pores of the porous magnesium alloy composite (×50). Comparing the porous AZ31 composite material and the porous AZ31 substrate, it can be seen that the outer surface of the pores of the porous AZ31 material after coating the polymer layer is smooth and dense, but the inside of the closed cells is relatively rough, which is mainly due to the interface effect of the polymer material coating. , this effect has a certain impact on the binding force between the polymer material and the substrate, and this effect is affected by the pore size and pore depth. The smaller the pore size, the stronger the interface effect. Therefore, in the comparison between Example 1 and subsequent examples Corrosion performance is slightly weak.

图5 SBF浸泡三个月后镁合金材料腐蚀对照图。图5a为多孔AZ31材料腐蚀图;图5b 为无孔AZ31复合材料腐蚀图;图5c为闭孔AZ31复合材料腐蚀图;图5d为通孔AZ31复合材料腐蚀图。对照未处理的多孔AZ31材料及经过聚乳酸处理后的AZ31材料,可见未处理过的AZ31材料,如图5a所示,其腐蚀三个月后已不具有完整的结构,而聚乳酸处理后的AZ31复合材料,如图5a-5d所示,该AZ31复合材料仍具有完整的结构,这一结果表明高分子材料的涂覆对提高AZ31材料的抗腐蚀性能具有重要的作用,结果与电化学结果吻合。 Figure 5 Corrosion control diagram of magnesium alloy material after SBF immersion for three months. Figure 5a is the corrosion diagram of porous AZ31 material; Figure 5b is the corrosion diagram of non-porous AZ31 composite material; Figure 5c is the corrosion diagram of closed-pore AZ31 composite material; Figure 5d is the corrosion diagram of through-hole AZ31 composite material. Compared with the untreated porous AZ31 material and the AZ31 material treated with polylactic acid, it can be seen that the untreated AZ31 material, as shown in Figure 5a, has no complete structure after three months of corrosion, while the porous AZ31 material treated with polylactic acid AZ31 composite material, as shown in Figure 5a-5d, the AZ31 composite material still has a complete structure, this result shows that the coating of polymer materials plays an important role in improving the corrosion resistance of AZ31 material, the results are consistent with the electrochemical results match.

图7多孔AZ31基材、与实施例1-4多孔AZ31复合材料塔菲尔曲线对照图。由塔菲尔曲线的Ecorr和Icorr可知,聚乳酸处理后的AZ31Ecorr提高了200mV, Icorr降低了将近4-5个数量级; Fig. 7 is a comparison diagram of the porous AZ31 substrate and the Tafel curve of the porous AZ31 composite material in Examples 1-4. From the Ecorr and Icorr of the Tafel curve, it can be seen that the AZ31 Ecorr after polylactic acid treatment increased by 200mV, and Icorr decreased by nearly 4-5 orders of magnitude;

图8多孔AZ31基材与实施例1-4多孔AZ31复合材料阻抗对照图。聚乳酸处理后AZ31阻抗较未处理时提高了5-6个数量级; Fig. 8 is a comparison diagram of the impedance of the porous AZ31 substrate and the porous AZ31 composite material of Examples 1-4. The impedance of AZ31 after treatment with polylactic acid increased by 5-6 orders of magnitude compared with that without treatment;

图9多孔AZ31基材与实施例1-6多孔AZ31复合材料Mg2+释放图。Mg2+释放浓度是反映材料在SBF中浸泡过程中腐蚀速率快慢的指标,Mg2+释放浓度越低说明浸泡过程中材料腐蚀速率越慢,从图9的结果可见闭孔复合材料比较,随着孔径的增大,材料腐蚀速率降低,这与图4的结果相吻合,说明大孔更利于高分子层的引入,进一步提高材料的抗腐蚀性能;通孔复合材料与闭孔复合材料相比具有更好的抗腐蚀性能,这主要是由于通孔复合材料孔内涂覆高分子材料时的界面效应小,更有利于高分子层与基底层的结合,增强复合材料的抗腐蚀性能。 Fig. 9 Mg 2+ release diagram of the porous AZ31 substrate and the porous AZ31 composite material of Examples 1-6. The release concentration of Mg 2+ is an index reflecting the corrosion rate of the material during immersion in SBF. The lower the release concentration of Mg 2+ means the slower the corrosion rate of the material during immersion. From the results in Figure 9, it can be seen that the comparison of closed-cell composite materials, with As the pore size increases, the corrosion rate of the material decreases, which is consistent with the results in Figure 4, indicating that the large pores are more conducive to the introduction of the polymer layer and further improve the corrosion resistance of the material; It has better corrosion resistance, which is mainly due to the small interface effect when the polymer material is coated in the hole of the through-hole composite material, which is more conducive to the combination of the polymer layer and the base layer, and enhances the corrosion resistance of the composite material.

实施例2:Example 2:

本实施例与实施例1的区别如下: The difference between this embodiment and embodiment 1 is as follows:

步骤1)中的区别在于: The difference in step 1) is:

a1取镁钙合金和镁锌合金制备铸态三元镁合金,该铸态三元镁合金中除镁元素外,钙元素和锌元素的重量占三元镁合金总重量百分比为4%;将步骤a1制备的铸态三元镁合金在300-350℃的条件下制成挤压态的三元镁合金; a1 get magnesium-calcium alloy and magnesium-zinc alloy to prepare as-cast ternary magnesium alloy, in this as-cast ternary magnesium alloy, except magnesium element, the weight of calcium element and zinc element accounts for ternary magnesium alloy gross weight percentage and is 4%; The cast ternary magnesium alloy prepared in step a1 is made into an extruded ternary magnesium alloy at a temperature of 300-350°C;

a2采用激光打孔机对a1制备的挤压态的三元镁合金的打孔,孔径为500μm、孔深度为300μm,孔隙率为50%; a2 uses a laser drilling machine to drill holes in the extruded ternary magnesium alloy prepared in a1, with a pore diameter of 500 μm, a hole depth of 300 μm, and a porosity of 50%;

步骤2)中的区别在于:制备的预处理层为磷化层,具体如下: The difference in step 2) is that the prepared pretreatment layer is a phosphating layer, as follows:

采用纯丙酮对步骤1)中制备的多孔镁合金基材进行清洗,清洗至无杂质; Cleaning the porous magnesium alloy substrate prepared in step 1) with pure acetone until there are no impurities;

然后,将经过清洗的多孔镁合金基材在温度为50℃的条件下,浓度为5%氢氧化钠溶液中浸泡15min,然后水洗,待用; Then, soak the cleaned porous magnesium alloy substrate in a 5% sodium hydroxide solution for 15 minutes at a temperature of 50° C., then wash with water, and set aside;

再将经过上述处理的多孔镁合金基材浸泡于磷化液中进行磷化处理,该磷化处理在室温条件下进行,处理时间为15min,其中,磷化液的配方为,1升磷化液中分别含磷酸25mL,氧化锌1g,氟化钠1g,亚硝酸钠1g,硝酸钠2g,焦磷酸钠2g,乙醇胺0.1g;最终获得磷化层的厚度为3μm。 Then soak the porous magnesium alloy base material treated above in a phosphating solution for phosphating treatment. The phosphating treatment is carried out at room temperature, and the treatment time is 15 minutes. Wherein, the formula of the phosphating solution is: The solution contains 25 mL of phosphoric acid, 1 g of zinc oxide, 1 g of sodium fluoride, 1 g of sodium nitrite, 2 g of sodium nitrate, 2 g of sodium pyrophosphate, and 0.1 g of ethanolamine; the thickness of the finally obtained phosphating layer is 3 μm.

步骤3)中的区别在于: The difference in step 3) is:

配制3wt.% 聚己内酯的三氯甲烷溶液; Prepare the chloroform solution of 3wt.% polycaprolactone;

再将经过步骤2)处理的多孔镁合金基材浸泡于所述3wt.% 聚己内酯的三氯甲烷溶液中,提出,然后在室温~60℃条件下将溶剂完全挥发,获得聚己内酯涂层,聚己内酯涂层的厚度为10μm。 Then soak the porous magnesium alloy substrate treated in step 2) in the chloroform solution of 3wt.% polycaprolactone, extract it, and then completely volatilize the solvent at room temperature to 60°C to obtain polycaprolactone Ester coating, the thickness of the polycaprolactone coating is 10 μm.

实施例3:Example 3:

本实施例与实施例1的区别之处如下: The difference between this embodiment and embodiment 1 is as follows:

步骤1)中的区别在于: The difference in step 1) is:

a1、取镁钙合金和镁锶合金制备铸态三元镁合金,该铸态三元镁合金中除镁元素外,钙元素和锶元素的重量占三元镁合金总重量百分比为4%,在300-350℃的条件下制成挤压态的三元镁合金; a1, get magnesium-calcium alloy and magnesium-strontium alloy to prepare as-cast ternary magnesium alloy, in this as-cast ternary magnesium alloy, except magnesium element, the weight of calcium element and strontium element accounts for ternary magnesium alloy gross weight percentage and is 4%, Extruded ternary magnesium alloy is made under the condition of 300-350℃;

a2、采用激光打孔机对a1制备的挤压态的三元镁合金的打孔,所述孔径为700μm、孔深度为400μm,孔隙率为55%; a2, using a laser drilling machine to punch holes in the extruded ternary magnesium alloy prepared by a1, the hole diameter is 700 μm, the hole depth is 400 μm, and the porosity is 55%;

步骤2)中的区别在于:制备的预处理层为磷化层,具体如下: The difference in step 2) is that the prepared pretreatment layer is a phosphating layer, as follows:

首先,采用纯酒精或纯丙酮对步骤1)中制备的多孔镁合金基材进行清洗,清洗至无杂质;在温度为50℃的条件下,浓度为5%氢氧化钠溶液中浸泡15min,然后水洗,待用; First, clean the porous magnesium alloy substrate prepared in step 1) with pure alcohol or pure acetone until there are no impurities; soak in 5% sodium hydroxide solution for 15 minutes at a temperature of 50°C, and then washed, ready to use;

然后,将经过上述处理的多孔镁合金基材浸泡于磷化液中进行磷化处理,该磷化处理在室温条件下进行,处理时间为15min,其中,磷化液的配方为:1升磷化液中分别含磷酸30mL,氧化锌1.5g,氟化钠2g,亚硝酸钠1.5g,硝酸钠3g,焦磷酸钠3g,乙醇胺1g;最终获得磷化层的厚度为7μm。 Then, soak the porous magnesium alloy base material treated above in a phosphating solution for phosphating treatment, the phosphating treatment is carried out at room temperature, and the treatment time is 15 minutes, wherein, the formula of the phosphating solution is: 1 liter of phosphorus The chemical solution contains 30 mL of phosphoric acid, 1.5 g of zinc oxide, 2 g of sodium fluoride, 1.5 g of sodium nitrite, 3 g of sodium nitrate, 3 g of sodium pyrophosphate, and 1 g of ethanolamine; the thickness of the finally obtained phosphating layer is 7 μm.

步骤3)中的区别在于: The difference in step 3) is:

配制5wt.% 聚酰胺的四氢呋喃溶液; Prepare a THF solution of 5wt.% polyamide;

将5wt.% 聚酰胺的四氢呋喃溶液分次滴定于经过步骤2)处理的多孔镁合金基材各表面上,然后在室温-60℃条件下将溶剂完全挥发,获得聚酰胺涂层,聚酰胺涂层的厚度为20μm。 Titrate 5wt.% polyamide tetrahydrofuran solution on each surface of the porous magnesium alloy substrate treated in step 2), and then completely evaporate the solvent at room temperature -60°C to obtain polyamide coating, polyamide coating The thickness of the layer was 20 μm.

实施例4:Example 4:

本实施例与实施例1的区别之处如下: The difference between this embodiment and embodiment 1 is as follows:

步骤1)中的区别在于: The difference in step 1) is:

a1、取镁钙合金和镁锶合金制备铸态三元镁合金,该铸态三元镁合金中除镁元素外,钙元素和锶元素的重量占三元镁合金总重量百分比为3%,在300-350℃的条件下制成挤压态的三元镁合金; a1, get magnesium-calcium alloy and magnesium-strontium alloy to prepare as-cast ternary magnesium alloy, in this as-cast ternary magnesium alloy, except magnesium element, the weight of calcium element and strontium element accounts for 3% of the total weight percentage of ternary magnesium alloy, Extruded ternary magnesium alloy is made under the condition of 300-350℃;

a2、采用激光打孔机对挤压态的三元镁合金的打孔,孔径为1000μm、孔深度为500μm,孔隙率为70%; a2. The extruded ternary magnesium alloy is drilled with a laser drilling machine, the hole diameter is 1000 μm, the hole depth is 500 μm, and the porosity is 70%;

步骤2)中的区别在于:制备的预处理层为磷化层,具体如下: The difference in step 2) is that the prepared pretreatment layer is a phosphating layer, as follows:

采用纯酒精或纯丙酮对步骤1)中制备的多孔镁合金基材进行清洗,清洗至无杂质;在温度为50℃的条件下,浓度为5%氢氧化钠溶液中浸泡15min,然后水洗,待用; Use pure alcohol or pure acetone to clean the porous magnesium alloy substrate prepared in step 1) until there are no impurities; soak in 5% sodium hydroxide solution for 15 minutes at a temperature of 50°C, and then wash with water. stand-by;

将经过上述处理的多孔镁合金基材浸泡于磷化液中进行磷化处理,该磷化处理在室温条件下进行,处理时间为15min,其中,磷化液的配方为,1升磷化液中分别含磷酸35mL,氧化锌2g,氟化钠3g,亚硝酸钠2g,硝酸钠4g,焦磷酸钠4g,乙醇胺2g;最终获得磷化层的厚度为10μm。 Soak the porous magnesium alloy base material treated above in a phosphating solution for phosphating treatment, the phosphating treatment is carried out at room temperature, and the treatment time is 15 minutes, wherein the formula of the phosphating solution is: 35mL of phosphoric acid, 2g of zinc oxide, 3g of sodium fluoride, 2g of sodium nitrite, 4g of sodium nitrate, 4g of sodium pyrophosphate, and 2g of ethanolamine were respectively contained in it; the thickness of the finally obtained phosphating layer was 10 μm.

步骤3)中的区别在于: The difference in step 3) is:

配制6wt.% 聚氨酯的四氢呋喃溶液; Prepare the THF solution of 6wt.% polyurethane;

将3wt.% 聚氨酯的四氢呋喃溶液分次滴定于经过步骤2)处理的多孔镁合金基材各表面上,然后在室温-60℃条件下将溶剂完全挥发,获得聚氨酯涂层,聚氨酯涂层的厚度为25μm。 Titrate 3wt.% polyurethane tetrahydrofuran solution on each surface of the porous magnesium alloy substrate treated in step 2), and then completely evaporate the solvent at room temperature -60°C to obtain a polyurethane coating. The thickness of the polyurethane coating is is 25 μm.

实施例5:Example 5:

本实施例与实施例1的区别之处如下: The difference between this embodiment and embodiment 1 is as follows:

步骤1)中的区别在于: The difference in step 1) is:

a1、取镁钙合金和镁锂合金制备铸态三元镁合金,该铸态三元镁合金中除镁元素外,钙元素和锂元素的重量占三元镁合金总重量百分比为3%,在300-350℃的条件下制成挤压态的三元镁合金; a1, get magnesium-calcium alloy and magnesium-lithium alloy to prepare as-cast ternary magnesium alloy, in this as-cast ternary magnesium alloy, except magnesium element, the weight of calcium element and lithium element accounts for ternary magnesium alloy gross weight percentage and is 3%, Extruded ternary magnesium alloy is made under the condition of 300-350℃;

a2、采用激光打孔机对a1制备的挤压态的三元镁合金的打孔,孔径为1000、孔深度为3000(通孔),孔隙率为70%; a2. Use a laser drilling machine to drill holes in the extruded ternary magnesium alloy prepared in a1. The hole diameter is 1000mm, the hole depth is 3000mm (through hole), and the porosity is 70%;

步骤2)中的区别在于制备的预处理层为磷化层,具体如下: The difference in step 2) is that the prepared pretreatment layer is a phosphating layer, as follows:

采用纯酒精或纯丙酮对步骤1)中制备的多孔镁合金基材进行清洗,清洗至无杂质;将经清洗的多孔镁合金基材在温度为50℃的条件下,浓度为5%氢氧化钠溶液中浸泡15min,然后水洗,待用; Clean the porous magnesium alloy substrate prepared in step 1) with pure alcohol or pure acetone until there is no impurity; oxidize the cleaned porous magnesium alloy substrate at a temperature of 50°C with a concentration of 5% hydrogen Soak in sodium solution for 15 minutes, then wash with water and set aside;

再将经过处理的多孔镁合金基材浸泡于磷化液中进行磷化处理,该磷化处理在室温条件下进行,处理时间为15min,其中,磷化液的配方为,1升磷化液中分别含磷酸35mL,氧化锌2g,氟化钠3g,亚硝酸钠2g,硝酸钠4g,焦磷酸钠4g,乙醇胺2g;最终获得磷化层的厚度为10μm。 Then soak the treated porous magnesium alloy base material in the phosphating solution for phosphating treatment, the phosphating treatment is carried out at room temperature, and the treatment time is 15min, wherein, the formula of the phosphating solution is, 35mL of phosphoric acid, 2g of zinc oxide, 3g of sodium fluoride, 2g of sodium nitrite, 4g of sodium nitrate, 4g of sodium pyrophosphate, and 2g of ethanolamine were respectively contained in it; the thickness of the finally obtained phosphating layer was 10 μm.

步骤3)中的区别在于: The difference in step 3) is:

配制6wt.% 聚乳酸的四氢呋喃溶液; Prepare a THF solution of 6wt.% polylactic acid;

将6wt.% 聚乳酸的四氢呋喃溶液分次滴定于经过步骤2)处理的多孔镁合金基材各表面上,然后在室温-60℃条件下将溶剂完全挥发,获得聚乳酸涂层,聚乳酸涂层的厚度为30μm。 Titrate 6wt.% polylactic acid tetrahydrofuran solution on each surface of the porous magnesium alloy substrate treated in step 2), and then completely evaporate the solvent at room temperature -60°C to obtain polylactic acid coating, polylactic acid coating The thickness of the layer was 30 μm.

实施例6:Embodiment 6:

本实施例与实施例1的区别在于: The difference between this embodiment and embodiment 1 is:

步骤1)中的区别在于:制备多孔镁合金的方法为熔体发泡加工法,具体如下: The difference in step 1) is that the method for preparing the porous magnesium alloy is a melt foaming processing method, specifically as follows:

a1、采用熔体发泡加工法制备多孔镁合金基材: a1. Prepare porous magnesium alloy substrate by melt foaming processing method:

取镁钙合金和镁锂合金制备铸态三元镁合金,该铸态三元镁合金中除镁元素外,钙元素和锂元素的重量占三元镁合金总重量百分比为3%;所述铸态三元镁合金熔融后添加Ca作为增粘剂,其含量为三元镁合金的10%;加入MgCO3作为发泡剂,其含量为三元镁合金的20%,制得的多孔镁合金基材中;平均孔径为500μm、平均孔深度为500μm,孔隙率为60%; Get magnesium-calcium alloy and magnesium-lithium alloy to prepare as-cast ternary magnesium alloy, in this as-cast ternary magnesium alloy, except magnesium element, the weight of calcium element and lithium element accounts for 3% of the total weight percentage of ternary magnesium alloy; After the as-cast ternary magnesium alloy is melted, Ca is added as a tackifier, whose content is 10% of the ternary magnesium alloy; MgCO3 is added as a foaming agent, whose content is 20% of the ternary magnesium alloy, and the obtained porous magnesium In the alloy substrate; the average pore diameter is 500 μm, the average pore depth is 500 μm, and the porosity is 60%;

步骤2)中的区别在于: The difference in step 2) is:

配制浓度为10%-30%的HF氧化液,将经清洗后的多孔镁合金基材在室温下浸泡于该氧化液中持续60s,从而在多孔镁合金基材表面及孔内获得氧化层,该氧化层的厚度为10μm; Prepare an HF oxidation solution with a concentration of 10%-30%, soak the cleaned porous magnesium alloy substrate in the oxidation solution for 60s at room temperature, so as to obtain an oxide layer on the surface and inside the pores of the porous magnesium alloy substrate, The thickness of the oxide layer is 10 μm;

步骤3)中的区别在于: The difference in step 3) is:

配制3wt.%聚乳酸的三氯甲烷溶液; Prepare a chloroform solution of 3wt.% polylactic acid;

将经过步骤2)处理的多孔镁合金基材浸泡于3wt.%聚乳酸的三氯甲烷溶液,提出,然后在室温~60℃条件下将溶剂完全挥发,获得聚乳酸层,聚乳酸层的厚度为10μm。 Soak the porous magnesium alloy substrate treated in step 2) in a 3wt.% polylactic acid solution in chloroform, extract it, and then completely evaporate the solvent at room temperature to 60°C to obtain a polylactic acid layer. The thickness of the polylactic acid layer is is 10 μm.

另外,所述步骤3)通过浸提法或者溶液滴定法制备高分子层涂层;对于含有通孔的多孔镁合金基材,为了使孔内高分子处理层处理均匀,还可以通过真空渗流法进行高分子处理层的处理。 In addition, the step 3) prepares the polymer layer coating by leaching method or solution titration method; for the porous magnesium alloy substrate containing through holes, in order to make the polymer treatment layer in the pores uniform, vacuum infiltration method can also be used Carry out the treatment of the polymer treatment layer.

表1中涉及的静置时间是指在进行塔菲尔曲线及阻抗测试时选择的静置时间,静置的目的在于提高待测材料 表面的稳定性。表中Icorr越小、Impedence越大表示复合材料的抗腐蚀性能越强。表中的Mg2+指采用SBF浸泡法测试复合材料耐腐蚀性能时所测得的参数,Mg2+释放浓度是反映材料在SBF中浸泡过程中腐蚀速率快慢的指标,Mg2+释放浓度越低说明浸泡过程中材料腐蚀速率越慢,Mg2+的测试方法是复合材料在SBF中浸泡21天后,取SBF液,采用原子吸收光谱法测试Mg2+的含量,空白SBF中Mg2+的含量为57 mg/L。 The resting time involved in Table 1 refers to the resting time selected during the Tafel curve and impedance test. The purpose of standing is to improve the stability of the surface of the material to be tested. In the table, the smaller the Icorr and the larger the Impedence, the stronger the corrosion resistance of the composite material. Mg 2+ in the table refers to the parameters measured when the SBF immersion method is used to test the corrosion resistance of composite materials. The Mg 2+ release concentration is an index reflecting the corrosion rate of the material during immersion in SBF. The higher the Mg 2+ release concentration Low means that the corrosion rate of the material is slower during the soaking process. The test method for Mg 2+ is to take the SBF liquid after the composite material is soaked in SBF for 21 days, and use the atomic absorption spectrometry to test the content of Mg 2+ . The content of Mg 2+ in the blank SBF The content is 57 mg/L.

表1中的对比例,指的是AZ31材料为基体的多孔AZ31材料。在相同条件下分别测试对比例、实施例1-6的Icorr、Impedence和Mg2+的释放浓度。 The comparative examples in Table 1 refer to the porous AZ31 material with the AZ31 material as the matrix. The release concentrations of Icorr, Impedence and Mg 2+ of the comparative example and Examples 1-6 were tested under the same conditions.

根据表1中的数据可知,实施例1-6中的的Icorr均小于对比例的Icorr,而Impedence均大于对比例的,这说明实施例1-6中的复合镁合金材料的抗腐蚀性能较对比例强,其中实施例6复合镁合金材料的耐腐蚀性能最强;表1中对比例中,多孔AZ31材料在SBF中浸泡21天后,取SBF液,采用原子吸收光谱法测试Mg2+的含量为328 mg/L,而实施例1-6中复合镁合金材料的Mg2+的含量均小于该数值,从而说明实施例1-6中复合镁合金材料的腐蚀速率较慢,其中实施例6复合镁合金材料的腐蚀速率最慢。 According to the data in table 1, the Icorr among the examples 1-6 is all less than the Icorr of the comparative examples, and the Impedence is all greater than that of the comparative examples, which shows that the corrosion resistance of the composite magnesium alloy material in the examples 1-6 is lower than that of the comparative examples. The comparative example is strong, wherein the corrosion resistance of the composite magnesium alloy material in Example 6 is the strongest; in the comparative example in table 1, after the porous AZ31 material was soaked in SBF for 21 days, the SBF solution was taken, and the atomic absorption spectrometry was used to test the Mg2+ content is 328 mg/L, and the content of Mg 2+ of composite magnesium alloy material in embodiment 1-6 is all less than this value, thus shows that the corrosion rate of composite magnesium alloy material in embodiment 1-6 is slower, wherein embodiment 6 The corrosion rate of the composite magnesium alloy material is the slowest.

参见图1和图2,图1为采用激光打孔法制备的多孔AZ31基材;该图中的激光打孔材料的孔径为1000μm,孔深500μm,孔间距1000μm。图2为采用发泡法制备的多孔镁、钙、锌三元镁合金基材;该图中熔体发泡材料的平均孔径及孔深大约为500μm。从图1和图2的对比可以发现采用激光打孔法制得的孔结构均匀、平滑,更有利于预处理层及高分子层的引入。 Referring to Figure 1 and Figure 2, Figure 1 is a porous AZ31 substrate prepared by laser drilling; the laser-drilled material in this figure has a pore diameter of 1000 μm, a hole depth of 500 μm, and a hole spacing of 1000 μm. Fig. 2 is a porous magnesium, calcium, zinc ternary magnesium alloy substrate prepared by foaming method; in this figure, the average pore diameter and pore depth of the melt foamed material are about 500 μm. From the comparison of Figure 1 and Figure 2, it can be found that the hole structure made by the laser drilling method is uniform and smooth, which is more conducive to the introduction of the pretreatment layer and the polymer layer.

参见图3 为镁合金基材及预处理层、高分子层。图3a为AZ31基材;图3b为氧化预处理层;图3c为磷化预处理层;图3d为高分子涂层。从表面结构来看,氧化层呈网络结构,EDS的结果表明氧化层的成分为MgO;聚乳酸涂层表面光滑,为致密的结构,这种致密的结构具有加强复合材料的抗腐蚀性能的作用。高分子层在提高复合材料抗腐蚀性能时除了考察高分子涂层的厚度,高分子涂层与基底层之间的结合力也是其中一个非常重要的因素,从实际应用考虑制备高分子层不宜过大,控制在10-20μm更为合适。 See Figure 3 for the magnesium alloy substrate, pretreatment layer, and polymer layer. Figure 3a is the AZ31 substrate; Figure 3b is the oxidation pretreatment layer; Figure 3c is the phosphating pretreatment layer; Figure 3d is the polymer coating. From the point of view of the surface structure, the oxide layer has a network structure, and the results of EDS show that the composition of the oxide layer is MgO; the surface of the polylactic acid coating is smooth and has a dense structure, and this dense structure can enhance the corrosion resistance of the composite material. . In addition to examining the thickness of the polymer coating when the polymer layer improves the corrosion resistance of the composite material, the bonding force between the polymer coating and the base layer is also a very important factor. Considering the practical application, the preparation of the polymer layer should not be too high. Larger, it is more appropriate to control it at 10-20μm.

参见图 6 AZ31复合材料SEM及EDS 图。图6a为无孔AZ31复合材料SEM图;图6b为闭孔AZ31复合材料SEM图;图6c为通孔AZ31复合材料SEM图;图6d为通孔AZ31复合材料孔内SEM图;图6e为通孔AZ31复合材料孔外SEM图。由图6可知在SBF中浸泡过程中,随着表面高分子层的逐渐降解,基底AZ31也逐渐腐蚀,并产生了晶体腐蚀产物,分析应为Mg(OH)2及MgO。 See Figure 6 for the SEM and EDS images of the AZ31 composite material. Figure 6a is the SEM image of the non-porous AZ31 composite; Figure 6b is the SEM image of the closed-pore AZ31 composite; Figure 6c is the SEM image of the through-hole AZ31 composite; Figure 6d is the SEM image of the through-hole AZ31 composite; The SEM image of the hole outside the hole of the AZ31 composite material. It can be seen from Figure 6 that during the immersion process in SBF, with the gradual degradation of the surface polymer layer, the substrate AZ31 is also gradually corroded, and crystal corrosion products are produced, which should be Mg(OH) 2 and MgO in analysis.

参见图10镁合金复合材料腐蚀示意图;腐蚀示意图显示镁合金的点腐蚀及聚乳酸腐蚀产物与镁合金腐蚀产物的相互作用与镁合金腐蚀的相互作用关系。研究表明镁合金的腐蚀方式主要为点蚀及均匀腐蚀,这与镁合金的晶粒大小有关,当晶粒较小,点蚀逐渐发展为均匀腐蚀,但是为了方便描述,本发明中的示意图,选择腐蚀起初的点蚀为模型。 See Figure 10 for a schematic diagram of the corrosion of magnesium alloy composite materials; the corrosion schematic diagram shows the pitting corrosion of magnesium alloys and the interaction between corrosion products of polylactic acid and corrosion products of magnesium alloys and the interaction relationship between corrosion of magnesium alloys. Studies have shown that the corrosion modes of magnesium alloys are mainly pitting corrosion and uniform corrosion, which is related to the grain size of magnesium alloys. When the grains are small, pitting corrosion gradually develops into uniform corrosion. However, for the convenience of description, the schematic diagram in the present invention, Pitting corrosion at the beginning of corrosion is selected as the model.

本发明采用可降解镁合金与可降解聚乳酸的复合,将镁合金的弹性模量、密度匹配性可调节性与聚合物的韧性、耐腐蚀性结合起来;同时,通过调节镁合金基材和涂层高分子材料的比例,可以方便控制材料的力学性能。本发明通过调节预处理层的成分可以调节高分子涂层与镁合金基材的结合力,从而更加可控地调节复合材料的可降解性。本发明通过调节镁合金的孔隙率及与聚合物的配比关系,能够获得具有良好骨匹配的复合材料,同时通过预处理层及聚合物处理层的复合可以有效解决镁合金耐腐蚀性能差的问题,从而获得与天然骨力学性能匹配、耐腐蚀性能优良的骨修复材料,有望在生物医学领域获得重要应用。 The present invention adopts the composite of degradable magnesium alloy and degradable polylactic acid to combine the elastic modulus and density matching adjustability of magnesium alloy with the toughness and corrosion resistance of polymer; at the same time, by adjusting the magnesium alloy substrate and The ratio of the coating polymer material can facilitate the control of the mechanical properties of the material. The invention can adjust the bonding force between the polymer coating and the magnesium alloy base material by adjusting the composition of the pretreatment layer, thereby more controllably adjusting the degradability of the composite material. The invention can obtain a composite material with good bone matching by adjusting the porosity of the magnesium alloy and the ratio relationship with the polymer, and at the same time, the problem of poor corrosion resistance of the magnesium alloy can be effectively solved by combining the pretreatment layer and the polymer treatment layer. In order to obtain a bone repair material that matches the mechanical properties of natural bone and has excellent corrosion resistance, it is expected to have important applications in the field of biomedicine.

最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管通过参照本发明的优选实施例已经对本发明进行了描述,但本领域的普通技术人员应当理解,可以在形式上和细节上对其作出各种各样的改变,而不偏离所附权利要求书所限定的本发明的精神和范围。 Finally, it is noted that the above embodiments are only used to illustrate the technical solutions of the present invention and not to limit them. Although the present invention has been described with reference to the preferred embodiments of the present invention, those skilled in the art should understand that it can be described in the form Various changes may be made in matter and details thereof without departing from the spirit and scope of the invention as defined in the appended claims.

表1: Table 1:

Claims (6)

1.一种生物医用耐蚀多孔复合材料的制备方法,其特征在于,所述生物医用耐蚀多孔复合材料由多孔镁合金基材、预处理层和聚合物涂层组成; 1. A method for preparing a biomedical corrosion-resistant porous composite material, characterized in that, the biomedical corrosion-resistant porous composite material is composed of a porous magnesium alloy substrate, a pretreatment layer and a polymer coating; 其中,多孔镁合金基材为AZ31,或镁含量大于90%的镁钙合金,或镁含量大于90%的镁钙合金与镁含量大于90%的镁锌合金、镁锂合金、镁锶合金分别形成的三元系合金;多孔镁合金基材的孔径为100~1200μm,闭孔的孔深度为100~500μm,孔隙率为30%~70%; Among them, the porous magnesium alloy substrate is AZ31, or a magnesium-calcium alloy with a magnesium content greater than 90%, or a magnesium-calcium alloy with a magnesium content greater than 90%, and a magnesium-zinc alloy, a magnesium-lithium alloy, and a magnesium-strontium alloy with a magnesium content greater than 90%. The formed ternary alloy; the pore diameter of the porous magnesium alloy substrate is 100-1200 μm, the pore depth of the closed cells is 100-500 μm, and the porosity is 30%-70%; 预处理层为磷化层,厚度为1~10μm; The pretreatment layer is a phosphating layer with a thickness of 1-10 μm; 聚合物涂层为可降解、脂肪族高分子材料层,厚度为5~30μm; The polymer coating is a degradable, aliphatic polymer material layer with a thickness of 5-30 μm; 制备方法具体包括如下步骤: The preparation method specifically comprises the following steps: 1)多孔镁合金基材的制备: 1) Preparation of porous magnesium alloy substrate: a、制备铸态的AZ31,或镁含量大于90%的镁钙合金,或镁含量大于90%的镁钙合金与镁含量大于90%的镁锌合金、镁锂合金、镁锶合金分别形成的三元系合金,该AZ31,或镁含量大于90%的镁钙合金,或镁含量大于90%的镁钙合金与镁含量大于90%的镁锌合金、镁锂合金、镁锶合金分别形成的三元系合金中除镁元素外,其他元素的重量占上述镁合金总重量百分比为<10%; a. Prepare as-cast AZ31, or magnesium-calcium alloy with magnesium content greater than 90%, or magnesium-calcium alloy with magnesium content greater than 90%, and magnesium-zinc alloy, magnesium-lithium alloy, and magnesium-strontium alloy with magnesium content greater than 90%. Ternary alloys, such as AZ31, or magnesium-calcium alloys with a magnesium content of more than 90%, or magnesium-calcium alloys with a magnesium content of more than 90% and magnesium-zinc alloys, magnesium-lithium alloys, and magnesium-strontium alloys with a magnesium content of more than 90%. Except magnesium element in ternary alloy, the weight percentage of other elements accounted for the total weight percentage of the above magnesium alloy is <10%; b、对所述多孔镁合金基材进行打孔处理; b. punching the porous magnesium alloy substrate; 2)多孔镁合金的预处理,在多孔镁合金基材表面及孔内采用磷化法获得分布均匀的磷化层作为后续聚合物涂层的中间层; 2) Pretreatment of the porous magnesium alloy, using the phosphating method on the surface and inside the pores of the porous magnesium alloy substrate to obtain a uniformly distributed phosphating layer as the intermediate layer of the subsequent polymer coating; 进行磷化的过程如下: The process of phosphating is as follows: a)多孔镁合金基材清洗:酒精或丙酮清洗; a) Porous magnesium alloy substrate cleaning: alcohol or acetone cleaning; b)碱洗脱脂:50℃的浓度为5%氢氧化钠溶液浸泡15min,水洗,待用; b) Alkaline washing and degreasing: soak in 5% sodium hydroxide solution at 50°C for 15 minutes, wash with water, and set aside; c)磷化处理:在室温下,磷化液中浸泡处理15min;磷化液的配方如下:磷酸:25~35mL/L,氧化锌:1~2g/L,氟化钠:1~3g/L,亚硝酸钠:1~2g/L,硝酸钠:2~4g/L,焦磷酸钠:2~4g/L,乙醇胺:0.1~2g/L; c) Phosphating treatment: Soak in phosphating solution for 15 minutes at room temperature; formula of phosphating solution is as follows: phosphoric acid: 25-35mL/L, zinc oxide: 1-2g/L, sodium fluoride: 1-3g/L L, sodium nitrite: 1~2g/L, sodium nitrate: 2~4g/L, sodium pyrophosphate: 2~4g/L, ethanolamine: 0.1~2g/L; 3)最后,将聚合物涂覆在多孔镁合金基材表面,通过改变聚合物的分子量、聚合物溶液的浓度、聚合物涂层的厚度,控制多孔镁合金基材与聚合物涂层的结合。 3) Finally, the polymer is coated on the surface of the porous magnesium alloy substrate, and the combination of the porous magnesium alloy substrate and the polymer coating is controlled by changing the molecular weight of the polymer, the concentration of the polymer solution, and the thickness of the polymer coating . 2.根据权利要求1所述生物医用耐蚀多孔复合材料的制备方法,其特征在于:所述的可降解、脂肪族高分子材料为聚乳酸、聚己内酯、聚酰胺或聚氨酯。 2. The preparation method of the biomedical corrosion-resistant porous composite material according to claim 1, characterized in that: the degradable and aliphatic polymer material is polylactic acid, polycaprolactone, polyamide or polyurethane. 3.根据权利要求1所述生物医用耐蚀多孔复合材料的制备方法,其特征在于:所述步骤1)中打孔采用激光打孔或熔体发泡法调节多孔镁合金的孔径及孔隙率; 3. The preparation method of the biomedical corrosion-resistant porous composite material according to claim 1, characterized in that: the drilling in the step 1) adopts laser drilling or melt foaming method to adjust the pore diameter and porosity of the porous magnesium alloy ; 熔体发泡法对铸态的AZ31或镁含量大于90%的镁钙合金,或镁含量大于90%的镁钙合金与镁含量大于90%的镁锌合金、镁锂合金、镁锶合金分别形成的三元系合金熔融,添加增稠剂、发泡剂进行熔融发泡,并调节发泡剂的含量及尺寸调节多孔镁合金的孔径及孔隙率;所述增稠剂为SiC或Ca;发泡剂为MgCO3、TiH2或ZrH2The melt foaming method is used for as-cast AZ31 or magnesium-calcium alloys with a magnesium content greater than 90%, or magnesium-calcium alloys with a magnesium content greater than 90% and magnesium-zinc alloys, magnesium-lithium alloys, and magnesium-strontium alloys with a magnesium content greater than 90%. The formed ternary alloy is melted, adding a thickener and a foaming agent for melting and foaming, and adjusting the content and size of the foaming agent to adjust the pore diameter and porosity of the porous magnesium alloy; the thickener is SiC or Ca; The blowing agent is MgCO 3 , TiH 2 or ZrH 2 . 4.根据权利要求1所述生物医用耐蚀多孔复合材料的制备方法,其特征在于:所述步骤3),采用浸润法或者滴液法将聚合物涂覆在多孔镁合金基材表面,或者真空渗流法进行高分子材料层的处理。 4. The preparation method of the biomedical corrosion-resistant porous composite material according to claim 1, characterized in that: in the step 3), the polymer is coated on the surface of the porous magnesium alloy substrate by the soaking method or the dripping method, or The vacuum infiltration method is used for the treatment of the polymer material layer. 5.根据权利要求1所述生物医用耐蚀多孔复合材料的制备方法,其特征在于,具体包括如下步骤: 5. the preparation method of biomedical corrosion-resistant porous composite material according to claim 1, is characterized in that, specifically comprises the following steps: 1)多孔镁合金基材的准备; 1) Preparation of porous magnesium alloy substrate; a1:取镁含量大于90%的镁钙合金和镁含量大于90%的镁锌合金、镁锂合金及镁锶合金中的任一种制备的铸态三元镁合金,该铸态三元镁合金中除镁元素外,其他元素的重量占三元镁合金总重量百分比为<10%,在300~350℃的条件下制成挤压态的三元镁合金; a1: As-cast ternary magnesium alloy prepared from any one of magnesium-calcium alloy with magnesium content greater than 90%, magnesium-zinc alloy, magnesium-lithium alloy, and magnesium-strontium alloy with magnesium content greater than 90%. In addition to the magnesium element in the alloy, the weight percentage of other elements in the total weight of the ternary magnesium alloy is less than 10%, and the extruded ternary magnesium alloy is made under the condition of 300-350°C; a2:采用激光打孔机对上述挤压态的三元镁合金打孔,孔径为100~1200μm,闭孔的孔深度为100~500μm,孔隙率为30~70%; a2: Use a laser drilling machine to drill holes in the extruded ternary magnesium alloy, with a pore diameter of 100-1200 μm, a closed hole depth of 100-500 μm, and a porosity of 30-70%; 2)磷化层的制备: 2) Preparation of phosphating layer: 采用纯酒精或纯丙酮对步骤1)准备的多孔镁合金基材进行清洗,清洗至无杂质; Clean the porous magnesium alloy substrate prepared in step 1) with pure alcohol or pure acetone until there are no impurities; 将经过上述清洗的多孔镁合金基材在温度为50℃的条件下,浓度为5%氢氧化钠溶液中浸泡15min,然后水洗;再将该多孔镁合金基材浸泡于磷化液中进行磷化处理,该磷化处理在室温条件下进行,处理时间为15min;其中,磷化液的配方为,1升磷化液中分别含磷酸25~35mL,氧化锌1~2g,氟化钠1~3g,亚硝酸钠1~2g,硝酸钠2~4g,焦磷酸钠2~4g,乙醇胺0.1~2g; Soak the porous magnesium alloy base material cleaned above at a temperature of 50°C in a 5% sodium hydroxide solution for 15 minutes, and then wash it with water; then soak the porous magnesium alloy base material in a phosphating solution for phosphorus Phosphating treatment, the phosphating treatment is carried out at room temperature, and the treatment time is 15 minutes; wherein, the formula of the phosphating solution is that 1 liter of the phosphating solution contains 25-35 mL of phosphoric acid, 1-2 g of zinc oxide, and 1 g of sodium fluoride. ~3g, sodium nitrite 1~2g, sodium nitrate 2~4g, sodium pyrophosphate 2~4g, ethanolamine 0.1~2g; 3)可降解、脂肪族高分子材料层的制备: 3) Preparation of degradable and aliphatic polymer material layer: c1、取平均分子量为5~30万的可降解、脂肪族高分子材料溶于易挥发的有机溶剂中,使可降解、脂肪族高分子材料的浓度为1%~10 %;所述易挥发的有机溶剂为二氯甲烷、三氯甲烷、丙酮或四氢呋喃; c1. Take a degradable and aliphatic polymer material with an average molecular weight of 50,000 to 300,000 and dissolve it in a volatile organic solvent, so that the concentration of the degradable and aliphatic polymer material is 1% to 10%; the volatile The organic solvent is dichloromethane, chloroform, acetone or tetrahydrofuran; 将经过步骤2)处理的多孔镁合金基材浸泡于c1的溶液中,提出,然后在室温~60℃条件下将溶剂完全挥发; soaking the porous magnesium alloy substrate treated in step 2) in the solution of c1, extracting it, and then completely volatilizing the solvent at room temperature to 60°C; 或将步骤c1制备的溶液分次滴加于经过步骤2)处理的多孔镁合金基材各表面上,然后在室温~60℃条件下将溶剂完全挥发。 Or add the solution prepared in step c1 dropwise onto each surface of the porous magnesium alloy substrate treated in step 2), and then completely volatilize the solvent at room temperature to 60°C. 6.根据权利要求5所述生物医用耐蚀多孔复合材料的制备方法,其特征在于,所述步骤1)的多孔镁合金基材采用熔体发泡法调节多孔镁合金的孔径及孔隙率,将步骤1)的镁含量大于90%的镁钙合金和镁含量大于90%的镁锌合金、镁锂合金及镁锶合金中的任一种制备的铸态三元镁合金,向其中添加增粘剂、发泡剂进行熔融发泡,通过调节发泡剂的含量及尺寸调节多孔镁合金的孔径、孔深度和孔隙率,制成多孔镁合金基材。 6. The preparation method of the biomedical corrosion-resistant porous composite material according to claim 5, characterized in that, the porous magnesium alloy base material in the step 1) adopts a melt foaming method to adjust the pore diameter and porosity of the porous magnesium alloy, The as-cast ternary magnesium alloy prepared by any one of the magnesium-calcium alloy with a magnesium content greater than 90% and the magnesium-zinc alloy, magnesium-lithium alloy, and magnesium-strontium alloy with a magnesium content greater than 90% in step 1) is added to it. The adhesive and foaming agent are melted and foamed, and the pore diameter, pore depth and porosity of the porous magnesium alloy are adjusted by adjusting the content and size of the foaming agent to prepare the porous magnesium alloy substrate.
CN201210449859.1A 2012-11-12 2012-11-12 Biomedical anti-corrosion porous compound material and preparation method thereof Expired - Fee Related CN102895706B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210449859.1A CN102895706B (en) 2012-11-12 2012-11-12 Biomedical anti-corrosion porous compound material and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210449859.1A CN102895706B (en) 2012-11-12 2012-11-12 Biomedical anti-corrosion porous compound material and preparation method thereof

Publications (2)

Publication Number Publication Date
CN102895706A CN102895706A (en) 2013-01-30
CN102895706B true CN102895706B (en) 2015-07-08

Family

ID=47568386

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210449859.1A Expired - Fee Related CN102895706B (en) 2012-11-12 2012-11-12 Biomedical anti-corrosion porous compound material and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102895706B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103272285B (en) * 2013-05-24 2014-12-03 华南理工大学 All-degradable biological material and preparation method thereof
CN103834830B (en) * 2014-03-31 2016-01-13 重庆大学 Application of mineral oil as foaming agent for preparing porous magnesium alloy and method for preparing porous magnesium alloy
CN106521216A (en) * 2016-11-09 2017-03-22 苏州大学 Preparation method for biological porous magnesium alloy
CN107639862B (en) * 2017-11-09 2019-05-17 北京工业大学 A kind of method of laser irradiation regulation PA2200 material 3D printing part surface wettability
CN109465170A (en) * 2018-09-26 2019-03-15 湖北大学 A coating for fast photohealing based on near-infrared laser response and its preparation method and application
CN111494704B (en) * 2020-04-14 2022-01-25 李贺杰 Method for preparing magnesium-based alloy biomaterial with small peptide coating and application thereof
CN112064091B (en) * 2020-08-21 2021-10-26 广东机电职业技术学院 Hole sealing method for micro-arc oxidation film layer
CN112877697B (en) * 2020-12-21 2023-03-21 重庆大学 Surface porous magnesium alloy and preparation method thereof
CN115068703A (en) * 2022-06-14 2022-09-20 南京浩衍鼎业科技技术有限公司 Preparation method of biodegradable developing material

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006004297A1 (en) * 2004-04-26 2006-01-12 Korea Institute Of Machinery And Materials Osseoinductive metal implants for a living body and producing method thereof
CN101032632A (en) * 2006-03-08 2007-09-12 中国科学院金属研究所 Material for bone tissue engineering scaffold and making method thereof
CN101455862A (en) * 2007-12-12 2009-06-17 中国科学院金属研究所 Preparation method of polyporous material for biological medicine tissue engineering scaffold
CN102397588A (en) * 2011-11-15 2012-04-04 东南大学 Porous magnesium alloy three-dimensional reinforced absorbable medical compound material and preparation method thereof
CN102580143A (en) * 2012-02-17 2012-07-18 浙江海圣医疗器械有限公司 Medical degradable and absorbable Mg-Sr system magnesium alloy implant and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006004297A1 (en) * 2004-04-26 2006-01-12 Korea Institute Of Machinery And Materials Osseoinductive metal implants for a living body and producing method thereof
CN101032632A (en) * 2006-03-08 2007-09-12 中国科学院金属研究所 Material for bone tissue engineering scaffold and making method thereof
CN101455862A (en) * 2007-12-12 2009-06-17 中国科学院金属研究所 Preparation method of polyporous material for biological medicine tissue engineering scaffold
CN102397588A (en) * 2011-11-15 2012-04-04 东南大学 Porous magnesium alloy three-dimensional reinforced absorbable medical compound material and preparation method thereof
CN102580143A (en) * 2012-02-17 2012-07-18 浙江海圣医疗器械有限公司 Medical degradable and absorbable Mg-Sr system magnesium alloy implant and preparation method thereof

Also Published As

Publication number Publication date
CN102895706A (en) 2013-01-30

Similar Documents

Publication Publication Date Title
CN102895706B (en) Biomedical anti-corrosion porous compound material and preparation method thereof
CN101461964B (en) Bioactivity surface modification method of biological medical degradable magnesium alloy
CN107460372B (en) A kind of Zn-Mn system kirsite and the preparation method and application thereof
CN107456610B (en) Zn-Ag series zinc alloy and preparation method and application thereof
Gao et al. Fabrication and characterization of bioactive composite coatings on Mg–Zn–Ca alloy by MAO/sol–gel
CN107456601B (en) Zn-Cu series zinc alloy and preparation method and application thereof
Nilawar et al. Surface engineering of biodegradable implants: Emerging trends in bioactive ceramic coatings and mechanical treatments
CN104911427B (en) A kind of Mg Ca Sr Zn systems magnesium alloy and preparation method and application
CN102580143A (en) Medical degradable and absorbable Mg-Sr system magnesium alloy implant and preparation method thereof
CN102552973A (en) Medical degradable and absorbable Mg-Sr-Ca series magnesium alloy implant and preparation method thereof
CN101709496A (en) Micro-arc oxidation-electrodeposition preparation method of magnesium-based bioactive coating
CN104451303A (en) Biomedical magnesium alloy and preparation method and application of biomedical magnesium alloy wire
Li et al. Preparing Ca-P coating on biodegradable magnesium alloy by hydrothermal method: In vitro degradation behavior
CN111407923B (en) Drug release controlled magnesium or magnesium alloy bionic bone and preparation method thereof
CN106310372A (en) Degradable magnesium-based bone implant drug-loaded high molecular/calcium-phosphorus composite coating and preparation method
Aufa et al. Surface enhancement of Ti–6Al–4V fabricated by selective laser melting on bone-like apatite formation
Zhao et al. Promotion of bone formation and antibacterial properties of titanium coated with porous Si/Ag-doped titanium dioxide
CN111676390B (en) A kind of Zn-Ga series alloy and its preparation method and application
Chowdhury et al. Advances in coatings on Mg alloys and their anti-microbial activity for implant applications
Liu et al. Formation characteristic of Ca–P coatings on magnesium alloy surface
Song et al. In situ alloying Ti–Ag antibacterial biomaterials via laser powder bed fusion: Microstructure, mechanical properties and bioperformance
CN113106295A (en) Degradable biomedical material Zn-Si-X series zinc alloy and preparation method thereof
CN106606806A (en) Zn-Mg1Ca series zinc alloy and preparing method and application of Zn-Mg1Ca series zinc alloy
CN106606800A (en) Zn-Fe system zinc alloy and preparation method and application thereof
Wang et al. Cytotoxicity and antibacterial efficacy of silver nanoparticles deposited onto dopamine-functionalised titanium

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150708

Termination date: 20211112